
Metart 25 Tablet ER
Marketer
Precise Lifescience
Salt Composition
Metoprolol Succinate (25mg)
Overview Metart 25 Tablet ER
CardioBeta 25 Extended Release tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also offers preventative benefits against migraine recurrence, future myocardial infarctions, and cerebrovascular accidents. CardioBeta 25 ER may be administered independently or in conjunction with other therapies; dosage and frequency are condition-specific. It can be consumed with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects might take several weeks to manifest, and continuous use may be necessary. Discontinuation can exacerbate underlying conditions, even in the absence of noticeable symptoms. Common adverse effects include fatigue, cephalalgia, depressive mood, bowel looseness, skin rashes, bradycardia, dizziness, and nausea – typically mild and transient. Less frequent side effects include dyspnea and hypotension. Gradual dose escalation is usually recommended to minimize adverse events. Consult your physician regarding persistent or bothersome side effects. Prior to initiating treatment, disclose any hepatic impairment. This medication is contraindicated in patients with pre-existing bradycardia, significant circulatory compromise, severe congestive heart failure, or hypotension. Pregnant or lactating individuals require prior medical consultation. Individual suitability should be determined through consultation with a healthcare professional. Regular blood pressure monitoring is essential to assess treatment effectiveness. Alcohol consumption should be minimized due to potential exacerbation of side effects.
Primary Ingredients of Metart 25 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Metart 25 Tablet ER
Managing angina pectoris (chest pain of cardiac origin) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (elevated blood pressure) | Preventing migraine headaches
Major Benefits of Metart 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Metart 25 Tablet ER whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. To maximize effectiveness, avoid consuming Metart 25 Tablet ER with meals high in fat, including those containing olive oil, nuts and seeds (especially Brazil nuts), dark chocolate, butter, or meat.
Common Side effects of Metart 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metart 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metart 25 Tablet ER. The tablet should be swallowed whole; do not crush, chew, or break it. While it can be taken with or without food, consistent timing is recommended. For best results, avoid consuming Metart 25 Tablet ER with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, or meat.
How Metart 25 Tablet ER works:
Metart 25 Extended-Release tablets are a cardioselective beta-adrenergic blocking agent. Their prolonged action reduces heart rate and improves the heart's pumping efficiency, thereby enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Metart 25 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metart 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metart 25 mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Metart 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Metart 25 Extended-Release tablets pose no safety concerns for individuals with kidney impairment; therefore, no dosage modification is necessary.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metart 25 Extended-Release tablets. Dosage modification of Metart 25 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metart 25 Tablet ER :
Should you forget to take a Metart 25 Tablet ER, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metart 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
